No Data
US Morning News Call | Musk Launches Grok-3 AI Chatbot, Competing with OpenAI and DeepSeek
Hong Kong Stock Early Report｜The three major US stock indices are closed for the holiday. TCL ELECTRONICS expects Net income to increase by over 60% year-on-year.
① Eight departments issued the "Action Plan for High-Quality Development of the New Energy Storage Manufacturing Industry." ② Sales of RBOB Gasoline Passenger Vehicles in the first month of this year dropped by over 20% compared to the previous month. ③ The Bank of Japan is likely to raise interest rates as early as May. ④ Baidu's gray testing for DeepSeek was launched today.
Peering Into Legend Biotech's Recent Short Interest
Goldman Sachs released a deep investment value report on China's Biomedical sector, highlighting a bullish outlook on ZAI LAB (ZLAB.US/9688.HK) and four other companies.
Recently, Goldman Sachs released an in-depth investment value analysis report on China's biotechnology. Goldman Sachs believes that it remains Bullish on the biotechnology sector within China's Medical and Healthcare market, as China's innovation is gaining and will continue to gain Global recognition. A number of leading biotechnology companies are expected to achieve breakeven in 2025/2026. This profitability inflection point is of milestone significance for China's biotechnology industry. Goldman Sachs also stated that ZAI LAB (ZLAB.US/9688.HK), Legend Biotech, INNOCARE, BEIGENE, and INNOVENT BIO are preferred symbols, as these companies have all experienced core catalytic events this year.
Why Legend Biotech Corporation (LEGN) Is Among the Best Healthcare Stocks To Buy According to Analysts
SA Asks: Which Big Pharmas Would Be Most Impacted by Higher Tariffs?
廣理右汛 : Support. Sending you a block.
adaptable Otter_3218 : Ag